©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: MediPharm Labs Corp.
Potts Out, Bumby in on MediPharm Labs Board
TORONTO -- MediPharm Labs Corp. board of directors member Shelley Potts will be stepping down effective December 31, 2025. Michael Bumby will replace her...
MediPharm Labs Reports Full Year and Q4 2024 Results
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids, announced its financial results for the full year and three months ended December 31, 2024.
MediPharm...
MediPharm Labs to Sell Hope Facility to Rubicon Organics for $4.5M
TORONTO - MediPharm Labs Corp. and Rubicon Organics Inc. have reached an agreement under which Rubicon will purchase MediPharm's facility in Hope, B.C., for $4.5 million in cash....
MediPharm Labs Terminates Proposed Sale of Facility to Kensana Health
TORONTO - MediPharm Labs Corp. terminated the previously announced sale of its facility in Napanee, Ontario, to Kensana Health Inc., which was to be completed...
MediPharm Labs Reports Third Quarter Results
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three and nine months ended September 30, 2024.
Key...
MediPharm Labs Announces $2.1M Debt Repayment
TORONTO - MediPharm Labs Corp., a specialized, research-driven pharmaceutical company focused on cannabis-based health products, has paid off the entire remaining convertible debt amount of $2.1...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids, has entered into a licencing agreement with Remidose Aerosols Inc. to acquire the...
MediPharm Labs Reports Fourth Quarter and Full Year 2023 Results
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the full year and three months ended...
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
TORONTO - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) a pharmaceutical company specialized in precision-based cannabinoids, received GMP certification for their Barrie, Ontario facility...
MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program
TORONTO - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) a pharmaceutical company specialized in precision-based cannabinoids, today announced an update regarding its Board...